Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2016-03-31
2018-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transcranial Direct Current Stimulation (tDCS) and Cognitive Task in Depression
NCT02296437
Depression and Transcranial Direct Current Stimulation (tDCS)
NCT00256438
Trial of Transcranial Direct Current Stimulation (tDCS) for Depression
NCT01263275
Home-Based Transcranial Direct Current Stimulation In Major Depressive Disorder (HOME)
NCT07228468
Trial of Transcranial Direct Current Stimulation (tDCS)
NCT01346306
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active tDCS
Soterix tDCS machine is used to administer active stimulation
Soterix tDCS machine
Soterix tDCS machine - miniCT supervised neuromodulation system
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Soterix tDCS machine
Soterix tDCS machine - miniCT supervised neuromodulation system
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Total MADRS score ≥ 20
Exclusion Criteria
* History of drug or alcohol abuse or dependence in the preceding 3 months
* High suicide risk
* Clinically defined neurological disorder or insult
* Metal in the cranium or skull defects
* Skin lesions on the scalp (e.g. cuts, abrasions, rashes) at the proposed electrode sites
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The University of New South Wales
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Colleen Loo
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Angelo Alonzo, BSc(Hons)/BA, PhD
Role: PRINCIPAL_INVESTIGATOR
University of New South Wales / Black Dog Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Black Dog Institute
Randwick, Sydney, New South Wales, Australia
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HC15010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.